Giant Biogene Holding Co., Ltd.
2367
Classifica tra le azioni
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Prezzo delle azioni
$2.67
Capitalizzazione di mercato
$2.84B
Variazione (1 giorno)
-6.09%
Variazione (1 anno)
-46.20%
Paese
CN
Scambia Giant Biogene Holding Co., Ltd. (2367)
Categoria
Consumer Defensive
Rapporto P/B per Giant Biogene Holding Co., Ltd. (2367)
Rapporto P/B al October 2026 TTM: 2.00
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Giant Biogene Holding Co., Ltd., il rapporto P/B attuale (TTM) è 2.00. Alla fine del 2024, era pari a 6.60.
Storico del rapporto P/B per Giant Biogene Holding Co., Ltd. da 2019 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 2.00 | -37.21% |
| 2025 | 3.19 | -51.68% |
| 2024 | 6.60 | -9.00% |
| 2023 | 7.25 | -29.02% |
| 2022 | 10.22 | -50.98% |
| 2021 | 20.85 | -57.14% |
| 2020 | 48.63 | 136.00% |
| 2019 | 20.61 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 6.9837 | 248.68% |
US
|
|
| 6.3772 | 218.40% |
FR
|
|
| 315.2455 | 15,639.45% |
US
|
|
| 8.7627 | 337.50% |
IN
|
|
| 9.8894 | 393.75% |
US
|
